Table 1 Characteristics of patients in the training set, test set, and validation cohort
Characteristic | Training set | p value | Test set | p value | Validation cohort | p value | |||
|---|---|---|---|---|---|---|---|---|---|
Agreement group (n = 69) | Disagreement group (n = 43) | Agreement group (n = 18) | Disagreement group (n = 11) | Agreement group (n = 30) | Disagreement group(n = 10) | ||||
Age | 62.449 ± 11.512 | 56.628 ± 10.137 | 0.008* | 61.611 ± 10.617 | 62.000 ± 9.633 | 0.922 | 59.167 ± 9.527 | 56.700 ± 9.719 | 0.485 |
Gender | 0.232 | 1.000 | 0.693 | ||||||
Men | 55 (79.7%) | 30 (69.8%) | 13 (72.2%) | 8 (72.7%) | 20 (66.7%) | 8 (80.0%) | |||
Female | 14 (20.3%) | 13 (30.2%) | 5 (27.8%) | 3 (27.3%) | 10 (33.3%) | 2 (20.0%) | |||
Lauren type | 0.404 | 0.785 | 0.208 | ||||||
Intestinal type | 30 (43.5%) | 24 (55.8%) | 8 (44.4%) | 6 (54.5%) | 14 (46.7%) | 2 (20.0%) | |||
Mixed type | 21 (30.4%) | 9 (20.9%) | 4 (22.2%) | 3 (27.3%) | 9 (30.0%) | 6 (60.0%) | |||
Diffuse type | 18 (26.1%) | 10 (23.3%) | 6 (33.3%) | 2 (18.2%) | 7 (23.3%) | 2 (20.0%) | |||
Lymph nodes Enlarged | 0.208 | 0.694 | 0.278 | ||||||
Yes | 47 (68.1%) | 34 (79.1%) | 13 (72.2%) | 7 (63.6%) | 9 (30.0%) | 5 (50.0%) | |||
No | 22 (31.9%) | 9 (20.9%) | 5 (27.8%) | 4 (36.4%) | 21 (70.0%) | 5 (50.0%) | |||
Location | 0.234 | 0.622 | 0.246 | ||||||
Cardia | 5 (7.2%) | 7 (16.3%) | 4 (22.2%) | 1 (9.1%) | 8 (26.7%) | 5 (50.0%) | |||
Non-cardia | 64 (92.8%) | 36 (83.7%) | 14 (77.8%) | 10 (90.9%) | 22 (73.3%) | 5 (50.0%) | |||
Thickness (mm) | 15.988 ± 5.837 | 15.941 ± 4.944 | 0.965 | 16.910(14.270–22.235) a | 15.870(14.190–16.145) a | 0.256 | 16.542 ± 5.036 | 18.043 ± 7.894 | 0.486 |
Longest diameter | 51.020(39.400–61.870) a | 52.760(39.135–65.245) a | 0.735 | 68.151 ± 32.823 | 50.374 ± 11.904 | 0.097 | 50.537 ± 20.657 | 49.085 ± 17.577 | 0.843 |